Tumor infiltrating lymphocytes (TILs): Lessons learned in 30 years of study

Clinical and Applied Immunology Reviews

Volumn 5, Issue 3, 2005, Pages 149-166

  Drescher, Kristen M ^a   Lynch, Henry T ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion molecules; Cancer; Cytokines; Fas; TILs

Indexed keywords

BETA1 INTEGRIN; BETA2 INTEGRIN; CD4 ANTIGEN; CD8 ANTIGEN; CELL PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PROTEIN BCL XL; PROTEIN C MYB; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER THERAPY; CARCINOGENESIS; CELL INTERACTION; COLORECTAL CANCER; DENDRITIC CELL; DISEASE MODEL; GENE EXPRESSION; GROWTH REGULATION; HUMAN; IMMUNE SYSTEM; IMMUNOSTIMULATION; LYMPHOCYTE COUNT; MELANOMA; METASTASIS POTENTIAL; MICROENVIRONMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR GROWTH;

EID: 20444441173     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cair.2005.03.002     Document Type: Review

References (83)

1. American Cancer Society Website. 2004.
2. K.S. Hughes Resection of the liver for colorectal-carcinoma metastases: a multi-institutional study of indications for resection Surgery 103 1988 278-288
3. E.J. Foley Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin Cancer Res 13 1953 835-837
4. K.C. Smith A.C. Bateman H.M. Fussell W.M. Howell Cytokine gene polymorphisms and breast cancer susceptibility and prognosis Eur J Immunogenet 31 2004 167-173
5. A. Loktionov Common gene polymorphisms, cancer progression and prognosis Cancer Lett 208 2004 1-33
6. A.M. Martin G. Athanasiadis J.D. Greshock J. Fisher M.P. Lux K. Calzone et al. Population frequencies of single nucleotide polymorphisms (SNPs) in immuno-modulatory genes Hum Hered 55 2003 171-178
7. E. Nakamura Y. Megumi T. Kobayashi T. Kamoto S. Ishitoya T. Terachi et al. Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population Clin Cancer Res 8 2002 2620-2625
8. E.S. Calhoun R.M. McGovern C.A. Janney J.R. Cerhan S.J. Iturria D.I. Smith et al. Host genetic polymorphism analysis in cervical cancer Clin Chem 48 2002 1218-1224
9. F. Brasseur M. Marchand R. Vanwijck M. Herin B. Lethe P. Chomez et al. Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors Int J Cancer 52 1992 839-841
10. U. Sahin M. Koslowski O. Tureci T. Eberle C. Zwick B. Romeike et al. Expression of cancer testis genes in human brain tumors Clin Cancer Res 6 2000 3916-3922
11. D. Murray A. Hreno J. Dutton L.G. Hampson Prognosis in colon cancer: A pathologic reassessment Arch Surg 110 1975 908-913
12. B.C. Sheu S.M. Hsu H.N. Ho R.H. Lin P.L. Torng S.C. Huang Reversed CD4/ CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma Cancer 86 1999 1537-1543
13. B. Mann A. Gratchev C. Bohm M.L. Hanski H.D. Foss G. Demel et al. FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas Br J Cancer 79 2002 1262-1269
14. K. Okada K. Komuta S. Hashimoto S. Matsuzaki T. Kanematsu T. Koji Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis Clin Cancer Res 6 2000 3560-3564
15. M.W. Bennett J. O'Connell G.C. O'Sullivan C. Brady D. Roche J.K. Collins et al. The fas counterattack in vivo: Apoptotic depletion of tumor-infiltrating lymphocytes associated with fas ligand expression by human esophageal carcinoma J Immunol 160 1998 5669-5675
16. B. Fisk B.W. Anderson K.R. Gravitt C.A. O'Brian A.P. Kudelka J.L. Murray Identification of naturally processed human ovarian peptides recognized by tumor-associated CD 8+ cytotoxic T lymphocytes Cancer Res 57 1997 87-93
17. D.C. Linehan P.S. Goedegebuure G.E. Peoples S.O. Rogers T.J. Eberlein Tumor-specific and HLA-A2-restricted cytolysis by tumor associated lymphocytes in human metastatic breast cancer J Immunol 155 1995 4486-4491
18. L. Puccetti R. Manetti P. Parronchi M.P. Piccinni C. Mavilia M. Carini et al. Role of low nuclear grading of renal carcinoma cells in the functional profile of tumor-infiltrating T cells Int J Cancer 98 2002 674-681
19. V. Groh R. Rhinehart H. Secrist S. Bauer K. Grabstein T. Spies Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICE Proc Natl Acad Sci U S A 96 1999 6879-6884
20. J.M. Michael-Robinson A.E. Biemer-Hüttmann D.M. Purdie M.D. Walsh L.A. Simms K.G. Biden et al. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status Gut 48 2001 360-366
21. R.F. Calhoun II B. Naziruddin F. Enriquez-Rincon B.F. Duffy J.M. Ritter S. Sundaresan et al. Evidence for cytotoxic T lymphocyte response against human lung cancer: Reconstitution of antigenic epitope with peptide eluted from lung adenocarcinoma MHC class I Surgery 128 2000 76-85
22. K. Schumacher W. Haensch C. Röefzaad P.M. Schlag Prognostic significance of activated CD8+ T cell infiltrations within esophageal carcinomas Cancer Res 61 2001 3932-3936
23. Y. Fukuzawa K. Takahashi K. Furuta T. Tagaya T. Ishikawa K. Wada et al. Expression of Fas/Fas ligand (FasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma J Gastroenterol 36 2001 681-688
24. C. Zietz U. Rumpler M. Stürzl U. Löhrs Inverse relation of fas-ligand and tumor-infiltrating lymphocytes in angiosarcanoma Am J Pathol 159 2001 963-970
25. N.S. Murthy A. Mathew Risk factors for pre-cancerous lesions of the cervix Eur J Cancer Prev 9 2000 5-14
26. R.A. Lothe P. Peltomaki G.I. Meling Genomic instability in colorectal cancer: Relationship to clinicopathological variables and family history Cancer Res 53 1993 5849-5852
27. C.M. Wright O.F. Cent M. Barker The prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer Br J Surg 87 2000 1197-1202
28. T.E. Reichert C. Scheuer R. Day W. Wagner T.L. Whiteside The number of intratumoral dendritic cells and ζ-chain expression in T Cells as prognostic and survival biomarkers in patients with oral carcinoma Cancer 91 2001 2136-2147
29. N.A. Zeid H.K. Muller S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival Pathology 25 1993 338-343
30. A. Kenji M. Masaki E. Munetomo S-100 protein-positive dendritic cells in colorectal adenocarcinomas Cancer 63 1989 496-503
31. S. Tsujitani Y. Kakeji Y. Maehara K. Sugimachi N. Kaibara Dendritic cells prevent lymph node metastasis in patients in gastric cancer In Vivo 7 1993 233-237
32. S.A. Goldman E. Baker R.J. Weyant M.R. Clarke J.N. Myers M.T. Lotze Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma Arch Otolaryngol Head Neck Surg 124 1998 641-646
33. S. Ishigama S. Natsugoe K. Tokuda A. Nakajo H. Higasi H. Iwashige et al. CD3-ζ chain expression of intratumoral lymphocytes is closely related to survival in gastric carcinoma patients Cancer 94 2002 1437-1442
34. T. Schwaab J.E. Weiss A.R. Schned R.J. Barth Dendritic cell infiltration in colon cancer J Immunother 24 2001 130-137
35. R.M. Dallal P. Christakos K. Lee S. Egawa Y.I. Son M.T. Lotze Paucity of dendritic cells in pancreatic cancer Surgery 131 2002 135-138
36. F. Tanaka W. Hashimoto H. Okamura P.D. Robbings M.T. Lotze H. Tahara Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells Cancer Res 60 2000 4838-4844
37. T. Tatsumi J. Huang W.E. Gooding A. Gambotto P.D. Robbins N.L. Vujanovic et al. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity Cancer Res 2003 2003 6378-6386
38. A. Suzuki A. Masuda H. Nagata S. Kameoka Y. Kikawada M. Yamakawa et al. Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma J Pathol 196 2002 37-43
39. H.Y. Wang T. Fu G. Wang G. Zeng D.M. Perry-Lalley J.C. Yang et al. Induction of CD4+ T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells J Clin Invest 109 2002 1463-1470
40. J.M. Sloan M.H. Kershaw C.E. Touloukian R. Lapointe P.F. Robbins N.P. Restifo et al. MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells Cancer Gene Ther 9 2002 946-950
41. M.H. Kershaw C. Hsu W. Mondesire L.L. Parker G. Wang W.W. Overwijk et al. Immunization against endogenous retroviral tumor-associated antigens Cancer Res 61 2001 7920-7924
42. W. Chen W. Jin N. Hardegen K.-J. Lei L. Li N. Marinos et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor of Foxp3 J Exp Med 198 2003 1875-1886
43. S. Sakaguchi N. Sakaguchi M. Asano M. Itoh M. Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151-1164
44. J. Shimizu S. Yamazaki S. Sakaguchi Induction of tumor immunity by removing CD25+CD4+ T cells: A common basis between tumor immunity and autoimmunity J Immunol 163 1999 5211-5218
45. F. Ichihara K. Kono A. Takahashi H. Kawaida H. Sugai H. Fujii Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers Clin Cancer Res 9 2003 4404-4408
46. A.M. Wolf D. Wolf M. Steurer G. Gastl E. Gunsilius B. Grubeck-Loebenstein Increase of regulatory T cells in the peripheral blood of cancer patients Clin Cancer Res 9 2003 606-612
47. A.M. Thornton E.M. Shevach CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro and by inhibiting interleukin 2 production J Exp Med 188 1998 289-296
48. B.H. Nelson IL-2, regulatory T cells, and tolerance J Immunol 172 2004 3983-3988
49. W.Z. Wei G.P. Morris Y.C. Kong Anti-tumor immunity and autoimmunity: A balancing act of regulatory T cells Cancer Immunol Immunother 53 2004 73-78
50. T.S. Griffith T. Brunner S.M. Fletcher D.R. Green T.A. Ferguson Fas ligand-induced apoptosis as a mechanism of immune privilege Science 270 1995 1189-1192
51. N.P. Restifo Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape Nat Med 6 2000 493-494
52. J.M. Michael-Robinson N. Pandeya M.C. Cummings M.D. Walsh J.P. Young B.A. Leggett et al. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status J Pathol 201 2003 46-54
53. M. Hahne D. Rimoldi M. Schroter P. Romero M. Schreier L.E. French et al. Melanoma cell expression of Fas (APO-1/CD95) ligand: Implications for tumor escape Science 274 1996 1363-1366
54. S.C. Lim Fas-related apoptosis in gastric adenocarcinoma Oncol Rep 10 2003 57-63
55. B. Bodey B. Bodey Jr. S.E. Siegel H.E. Kaiser Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas Anticancer Res 19 1999 3293-3314
56. J. O'Connell G.C. O'Sullivan J.K. Collins F. Shanahan The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand J Exp Med 184 1996 1075-1082
57. J. O'Connell M.W. Bennett G.C. O'Sullivan D. Roche J. Kelly J.K. Collins et al. Fas ligand expression in primary colon adenocarcinomas: Evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer J Pathol 186 1998 240-246
58. C. Liu J.H. Chiu T. Chin L.S. Wang A.F. Li K.C. Chow et al. Expression of fas ligand on bile ductule epithelium in biliary atresia - a poor prognostic factor J Pediatr Surg 35 2000 1591-1596
59. K.F. Yoong S.C. Afford S. Randhawa S.G. Hubscher D.H. Adams Fas/Fas ligand interaction in human colorectal hepatic metastases Am J Pathol 154 1999 693-703
60. J. O'Connell M.W. Bennett G.C. O'Sullivan J. O'Callaghan J.K. Collins F. Shanahan Expression of fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege Clin Diagn Lab Immunol 6 1999 457-463
61. M.W. Bennett J. O'Connell G.C. O'Sullivan D. Roche C. Brady J. Kelly et al. Expression of fas ligand by human gastric adenocarcinomas: A potential mechanism of immune escape in stomach cancer Gut 44 1999 156-162
62. K. Asanuma N. Tsuji T. Endoh A. Yagihashi N. Watanabe Survivin enhances fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells J Immunol 172 2004 3922-3929
63. A. Houston M.W. Bennett G.C. O'Sullivan F. Shanahan J. O'Connell Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-β expression Br J Cancer 89 2003 1345-1351
64. J.J. Chen Y. Sun G.J. Nabel Regulation of the proinflammatory effects of Fas ligand (CD95) Science 282 1998 1714-1717
65. A. Biroccio B. Benassi I. D'Agnano C. D'Angelo S. Buglioni M. Mottolese et al. c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer Am J Pathol 158 2001 1289-1299
66. J.P. Johnson B.G. Stade B. Holzmann W. Schwäble G. Riethmüller De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis Proc Natl Acad Sci U S A 86 1989 641-644
67. K. Maeda S.M. Kang T. Sawada Y. Nishiguchi M. Yashiro Y. Ogawa et al. Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer Oncol Rep 9 2002 511-514
68. P.G. Natali C.V. Hamby B. Felding-Habermann B. Liang M.R. Nicotra F. DiFilippo et al. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions Cancer Res 57 1997 1554-1560
69. S. Koyama T. Ebihara K. Fukao Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma J Cancer Res Clin Oncol 118 1992 609-614
70. J. Kitayama H. Nagawa H. Nakayama N. Tuno Y. Shibata T. Muto Functional expression of β1 and β2 integrins on tumor infiltrating lymphocytes (TILs) in colorectal cancer J Gastroenterol 34 1999 327-333
71. S.M. Lippman C.M. Spier T.P. Miller D.J. Slymen J.A. Rybski T.M. Grogan Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course Mod Pathol 3 1990 361-367
72. A.T. Stopeck A. Gessner T.P. Miller E.M. Hersh C.S. Johnson H. Cui et al. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma Clin Cancer Res 6 2000 3904-3909
73. E. Horst C.J.L.M. Meijer T. Radaszkiewic G.J. Ossekopple J.H.J.M. van Krieken S.T. Pals Adhesion molecules in the prognosis of diffuse large-cell lymphoma: Expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54) Leukemia 4 1990 595-599
74. L.J. Medeiros L.M. Weiss L.J. Picker C. Clayberger S.J. Horning A.M. Krensky et al. Expression of LFA-1 in non-Hodgkin's lymphoma Cancer 63 1989 255-259
75. M.F. Yuen R.D. Hughes M.A. Heneghan P.G. Langley S. Norris Expression of fas antigen (CD95) in peripheral blood lymphocytes and in liver-infiltrating, cytotoxic lymphocytes in patients with hepatocellular carcinoma Cancer 92 2001 2136-2141
76. E. Riedl H. Strobl O. Majdic W. Knapp TGF-β1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis J Immunol 158 1997 1591-1597
77. I. Dybedal F. Guan O.J. Borge O.P. Veiby V. Ramsfjell S. Nagata et al. Transforming growth factor-β1 abrogates fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells Blood 90 1997 2284-3403
78. F. De Paola A. Riccobon E. Flamini F. Barzanti A.M. Granato G.L. Mordenti et al. Restored T-cell activation mechanisms in human tumor-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2 Br J Cancer 88 2003 320-326
79. I. Tamm T. Kikutami I. Cardinale J.G. Krueger Cell-adhesion-disrupting action of interleukin-6 in human ductal breast carcinoma cells Proc Natl Acad Sci U S A 91 1994 3329-3333
80. I. Tamm I. Cardinale T. Kikutami J.G. Krueger E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells Proc Natl Acad Sci U S A 91 1994 4338-4342
81. T. Kanai M. Watanabe A. Hayashi A. Nakazawa T. Yajima A. Okazawa et al. Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion Br J Cancer 82 2000 1717-1723
82. B.C. Sheu R.H. Lin H.C. Lien H.N. Ho S.M. Hsu S.C. Huang Predominant Th2/ Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer J Immunol 167 2001 2972-2978
83. W. von Bernstorff M. Voss S. Freichel A. Schmid I. Vogel C. Jöhnk et al. Systemic and local immunosuppression in pancreatic cancer patients Clin Cancer Res 7 2001 925s-932s